Such a significant association has been reported in many studies linking CYP4Z1 expression with poor patient survival and connecting it to aggressive characteristics of cancers such as breast, colon, prostate, cervical, and ovarian cancers [13,14,15,16,17]. This evidence concerns the gene CYP4Z1 and cancer.